Mastocytosis: Part I: Pathogenesis, Clinical Presentation and Classification

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Mast cells are crucial immune cells involved in homeostasis, immunity, and tissue repair.
• Mastocytosis is a neoplastic proliferation of mast cells, leading to diverse clinical manifestations.
• Recent advances in mast cell signaling reveal potential new drug targets.

Purpose of the Study:

• To review the pathophysiology, clinical presentation, and classification of mastocytosis.
• To highlight the role of mast cell mediators in disease symptoms.
• To discuss the World Health Organization classification and prognostic factors.

Main Methods:

• Review of current literature on mastocytosis.
• Analysis of clinical and pathological findings.
• Synthesis of World Health Organization classification criteria.

Main Results:

• Mastocytosis presents with varied cutaneous and systemic symptoms due to mast cell infiltration and mediator release.
• Classification includes indolent, smoldering, aggressive forms, and associated neoplasms.
• Prognosis is highly dependent on the specific subtype and associated findings.

Conclusions:

• Mastocytosis is a complex hematologic neoplasm with a wide spectrum of clinical presentations and outcomes.
• Targeting mast cell activation pathways holds promise for novel therapeutic strategies.
• Accurate classification is essential for determining prognosis and guiding patient management.